Browsing Tag
Drug discovery
46 posts
PharmaEngine collaborates with Sentinel Oncology for cancer drug development
PharmaEngine, a Taiwanese pharmaceutical company, has entered a strategic collaboration and licensing agreement with UK-based Sentinel Oncology to…
December 6, 2020
PerkinElmer acquisition of Horizon Discovery Group: A strategic move to enhance genomic and cell engineering capabilities
PerkinElmer, a leading US-based provider of life sciences and diagnostics solutions, has announced its acquisition of Horizon Discovery…
November 3, 2020
Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex
US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a…
August 11, 2020
Curi Bio acquires Dana Solutions to boost drug discovery platforms
Curi Bio, a developer of human iPSC-based platforms for drug discovery, has acquired Dana Solutions, a provider of…
July 25, 2020
Cyclica, Genome Institute of Singapore sign drug discovery partnership
Canadian biotech company Cyclica has signed a multi-year and multi-project drug discovery partnership with the Genome Institute of…
April 14, 2020
Gilead Sciences, Second Genome form IBD drug discovery alliance
Gilead Sciences has entered into a four-year deal worth up to $338 million with California-based clinical-stage company Second…
April 9, 2020
Polarisqb, Fujitsu join forces to create dengue drug discovery platform
Polarisqb has joined forces with Fujitsu to create a Dengue drug discovery platform that brings together quantum-inspired technology,…
March 20, 2020
AbbVie, Scripps Research to collaborate on developing new therapeutics
US biopharma company AbbVie has entered into a collaboration with California-based nonprofit medical research facility Scripps Research with…
December 10, 2019
GE Healthcare, ASLS form R&D partnership to advance 3D biofabrication
GE Healthcare Life Sciences has joined forces with Advanced Solutions Life Sciences (ASLS) for an R&D and distribution…
December 9, 2019
AstraZeneca taps into Gatehouse Bio’s sRNAlytics AI platform for drug discovery
US biodata company Gatehouse Bio is joining forces with pharma giant AstraZeneca to accelerate the discovery of new…
December 5, 2019